Today, the Centers for Medicare & Medicaid Services (CMS) released a manufacturer release (Release No. 113) to address how manufacturers can ensure they are complying with reporting obligation and requirements of the Medicaid Drug Rebate Program for their covered outpatient drugs. CMS is providing this guidance to ensure that manufactures can determine if they are correctly reporting their data and describes some of the steps that manufacturers should take if corrections are required.
Upon entering the program, and each month and quarter thereafter, manufacturers must report certain pricing and product data to CMS to meet statutory and regulatory requirements for participation. This data help to determine the rebates that manufacturers pay to states for prescription drugs provided to state Medicaid beneficiaries.
.png)
No hay comentarios:
Publicar un comentario